Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 338
Filter
1.
Skin Health Dis ; 2(2): e95, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35677930

ABSTRACT

Background: Renal transplant recipients (RTRs) are at increased risk of keratinocyte cancer (KC), especially cutaneous squamous cell carcinoma (cSCC). Previous studies identified a genetic variant of the Methylenetetrahydrofolate Reductase (MTHFR) gene, C677T, which conferred a risk for diagnosis of cSCC in Irish RTRs. Objective: We sought to find further genetic variation in MTHFR and overlap genes that may be associated with a diagnosis of KC in RTRs. Methods: Genotyping of a combined RTR population (n = 821) from two centres, Ireland (n = 546) and the USA (n = 275), was performed. This included 290 RTRs with KC and 444 without. Eleven single nucleotide polymorphisms (SNPs) in the MTHFR gene and seven in the overlap gene MTHFR Chloride transport protein 6 (CLCN6) were evaluated and association explored by time to event analysis (from transplant to first KC) using Cox proportional hazards model. Results: Polymorphism at MTHFR CLCN6 (rs9651118) was significantly associated with KC in RTRs (HR 1.50, 95% CI 1.17-1.91, p < 0.00061) and cSCC (HR 1.63, 95% CI 1.14-2.34, p = 0.007). A separate SNP, MTHFR C677T, was also significantly associated with KC in the Irish population (HR 1.31, 95% CI 1.05-1.63, p = 0.016), but not American RTRs. Conclusions: We report the association of a SNP in the MTHFR overlap gene, CLCN6 and KC in a combined RTR population. While the exact function of CLCN6 is not known, it is proposed to be involved in folate availability. Future applications could include incorporation in a polygenic risk score for KC in RTRs to help identify those at increased risk beyond traditional risk factor assessment.

2.
3.
JPRAS Open ; 15: 81-85, 2018 Mar.
Article in English | MEDLINE | ID: mdl-32158803

ABSTRACT

Pyoderma gangrenosum (PG) is a rare and painful idiopathic skin condition that has one or more areas of chronic ulceration with well demarcated and undermined borders. Bone osteolysis (the pathological destruction of bone tissue) secondary to PG is a rare phenomenon with limited cases reported in children only. This is the first case report of scalp PG with cranial osteolysis in an 80-year-old adult, with an initial presentation mimicking skin carcinoma. This case highlights the importance of a multidisciplinary team (MDT) meeting discussion, diagnosis of PG by exclusion and the successful treatment of this patient's PG eroding to the bone.

5.
Mol Psychiatry ; 22(4): 527-536, 2017 04.
Article in English | MEDLINE | ID: mdl-27528460

ABSTRACT

The hypothalamic-pituitary-adrenal (HPA) axis has been implicated in the pathophysiology of a variety of mood and cognitive disorders. Neuroendocrine studies have demonstrated HPA axis overactivity in major depression, a relationship of HPA axis activity to cognitive performance and a potential role of HPA axis genetic variation in cognition. The present study investigated the simultaneous roles HPA axis activity, clinical symptomatology and HPA genetic variation play in cognitive performance. Patients with major depression with psychotic major depression (PMD) and with nonpsychotic major depression (NPMD) and healthy controls (HC) were studied. All participants underwent a diagnostic interview and psychiatric ratings, a comprehensive neuropsychological battery, overnight hourly blood sampling for cortisol and genetic assessment. Cognitive performance differed as a function of depression subtype. Across all subjects, cognitive performance was negatively correlated with higher cortisol, and PMD patients had higher cortisol than did NPMDs and HCs. Cortisol, clinical symptoms and variation in genes, NR3C1 (glucocorticoid receptor; GR) and NR3C2 (mineralocorticoid receptor; MR) that encode for GRs and MRs, predicted cognitive performance. Beyond the effects of cortisol, demographics and clinical symptoms, NR3C1 variation predicted attention and working memory, whereas NR3C2 polymorphisms predicted memory performance. These findings parallel the distribution of GR and MR in primate brain and their putative roles in specific cognitive tasks. HPA axis genetic variation and activity were important predictors of cognition across the entire sample of depressed subjects and HR. GR and MR genetic variation predicted unique cognitive functions, beyond the influence of cortisol and clinical symptoms. GR genetic variation was implicated in attention and working memory, whereas MR was implicated in verbal memory.


Subject(s)
Depressive Disorder, Major/metabolism , Hydrocortisone/metabolism , Hydrocortisone/physiology , Receptors, Glucocorticoid/genetics , Adult , Bipolar Disorder/physiopathology , Brain/physiopathology , Cognition/physiology , Cognition Disorders/physiopathology , Depressive Disorder, Major/blood , Depressive Disorder, Major/physiopathology , Female , Genetic Variation/genetics , Humans , Hydrocortisone/blood , Hypothalamo-Hypophyseal System/physiopathology , Male , Middle Aged , Pituitary-Adrenal System/physiopathology , Polymorphism, Single Nucleotide/genetics , Psychotic Disorders/physiopathology , Receptors, Mineralocorticoid/genetics
7.
Pharmacogenomics J ; 15(4): 332-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25487678

ABSTRACT

The hypothesis that allelic variation in the multidrug resistance-1 (MDR1 or ABCB1) gene encoding the P-glycoprotein (P-gp) blood-brain barrier efflux pump is associated with remission and side effects was tested in chronic major depression patients treated with P-gp substrates. In 83 patients from the REVAMP trial, frequency of and time to remission as well as side effects was tested among genotype groups at 6 ABCB1 single nucleotide polymorphisms (SNPs). These six SNPs are significantly associated with remission and time to remission, with minor allele carriers on rs2235040 and rs9282564 attaining statistical significance after controlling for the other ABCB1 SNPs. The six ABCB1 SNPs are also significantly associated with the average side effects. However, here common homozygotes on rs2235040 and rs9282564 demonstrated significantly higher side effects after controlling for the effects of the other ABCB1 SNPs. These findings confirm and extend previous observations that minor alleles of two ABCB1 SNPs predict remission to treatment with substrates and demonstrate that common homozygotes on these SNPs experience greater side effects. Results point to the potential importance of ABCB1 variation for personalized medicine approaches to treating depression.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Antidepressive Agents/therapeutic use , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/genetics , ATP Binding Cassette Transporter, Subfamily B/genetics , Adult , Alleles , Antidepressive Agents/administration & dosage , Antidepressive Agents/adverse effects , Chronic Disease , Dose-Response Relationship, Drug , Female , Genotype , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Polymorphism, Single Nucleotide , Sertraline/therapeutic use , Treatment Outcome , White People
8.
Ir J Med Sci ; 184(1): 75-6, 2015 Mar.
Article in English | MEDLINE | ID: mdl-24913736

ABSTRACT

INTRODUCTION: Lichen planus is an inflammatory mucocutaneous disorder, often idiopathic. It is postulated that the characteristic skin lesions arise from a T cell mediated autoimmune response against basal keratinocytes. Oral mucosal involvement can occur in up to 70 % of cases of cutaneous disease however, oesphageal involvement is rare. RESULT: We report the case of a 60 year old female with ulcerative oesphagitis and concomitant cutaneous lesions suggestive of lichen planus. Multiple immunosuppressant therapies were administered but with little success, except for pulses of oral steroids. CONCLUSION: Oesphageal lichen planus is rare, often unrecognised and can be resistant to treatment. However, diagnosis is crucial as malignant transformation of longstanding ulcerative lichen planus may occur.


Subject(s)
Esophageal Diseases/drug therapy , Lichen Planus/drug therapy , Skin Diseases/drug therapy , Esophageal Diseases/pathology , Female , Humans , Immunosuppressive Agents/therapeutic use , Lichen Planus/pathology , Middle Aged , Skin Diseases/pathology
9.
Mol Psychiatry ; 19(2): 220-7, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24166410

ABSTRACT

Genetic variation underlying hypothalamic pituitary adrenal (HPA) axis overactivity in healthy controls (HCs) and patients with severe forms of major depression has not been well explored, but could explain risk for cortisol dysregulation. In total, 95 participants were studied: 40 patients with psychotic major depression (PMD); 26 patients with non-psychotic major depression (NPMD); and 29 HCs. Collection of genetic material was added one third of the way into a larger study on cortisol, cognition and psychosis in major depression. Subjects were assessed using the Brief Psychiatric Rating Scale, the Hamilton Depression Rating Scale and the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders. Blood was collected hourly for determination of cortisol from 1800 to 0900 h and for the assessment of alleles for six genes involved in HPA axis regulation. Two of the six genes contributed significantly to cortisol levels, psychosis measures or depression severity. After accounting for age, depression and psychosis, and medication status, only allelic variation for the glucocorticoid receptor (GR) gene accounted for a significant variance for mean cortisol levels from 1800 to 0100 h (r(2)=0.288) and from 0100 to 0900 h (r(2)=0.171). In addition, GR and corticotropin-releasing hormone receptor 1 (CRHR1) genotypes contributed significantly to psychosis measures and CRHR1 contributed significantly to depression severity rating.


Subject(s)
Affective Disorders, Psychotic/genetics , Depressive Disorder, Major/genetics , Hydrocortisone/blood , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/physiopathology , Adult , Affective Disorders, Psychotic/diagnosis , Affective Disorders, Psychotic/physiopathology , Corticotropin-Releasing Hormone/genetics , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/physiopathology , Female , Humans , Interview, Psychological , Linkage Disequilibrium , Male , Psychiatric Status Rating Scales , Receptors, Corticotropin-Releasing Hormone/genetics , Receptors, Glucocorticoid/genetics , Receptors, Mineralocorticoid/genetics , Tacrolimus Binding Proteins/genetics
10.
Am J Transplant ; 13(8): 2146-53, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23718915

ABSTRACT

Primary cutaneous posttransplant lymphoproliferative disorders (PTLD) are rare. This retrospective, multicenter study of 35 cases aimed to better describe this entity. Cases were (re)-classified according to the WHO-EORTC or the WHO 2008 classifications of lymphomas. Median interval between first transplantation and diagnosis was 85 months. Fifty-seven percent of patients had a kidney transplant. Twenty-four cases (68.6%) were classified as primary cutaneous T cell lymphoma (CTCL) and 11 (31.4%) as primary cutaneous B cell PTLD. Mycosis fungoides (MF) was the most common (50%) CTCL subtype. Ten (90.9%) cutaneous B cell PTLD cases were classified as EBV-associated B cell lymphoproliferations (including one plasmablastic lymphoma and one lymphomatoid granulomatosis) and one as diffuse large B cell lymphoma, other, that was EBV-negative. Sixteen (45.7%) patients died after a median follow-up of 19.5 months (11 [68.8%] with CTCL [6 of whom had CD30(+) lymphoproliferative disorders (LPD)] and 5 [31.2%] with cutaneous B cell PTLD. Median survival times for all patients, CTCL and cutaneous B cell PTLD subgroups were 93, 93, and 112 months, respectively. Survival rates for MF were higher than those for CD30(+) LPD. The spectrum of primary CTCL in organ transplant recipients (OTR) is similar to that in the general population. The prognosis of posttransplant primary cutaneous CD30(+) LPD is worse than posttransplant MF and than its counterpart in the immunocompetent population. EBV-associated cutaneous B cell LPD predominates in OTR.


Subject(s)
Lymphoma, T-Cell, Cutaneous/etiology , Lymphoproliferative Disorders/etiology , Mycosis Fungoides/etiology , Organ Transplantation/adverse effects , Postoperative Complications , Skin Neoplasms/etiology , Female , Follow-Up Studies , Humans , International Agencies , Lymphoma, T-Cell, Cutaneous/diagnosis , Lymphoma, T-Cell, Cutaneous/mortality , Lymphoproliferative Disorders/diagnosis , Lymphoproliferative Disorders/mortality , Male , Middle Aged , Mycosis Fungoides/diagnosis , Mycosis Fungoides/mortality , Prognosis , Retrospective Studies , Risk Factors , Skin Neoplasms/diagnosis , Skin Neoplasms/mortality , Survival Rate
11.
Br J Dermatol ; 164(6): 1201-13, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21418174

ABSTRACT

In recent years, the contribution of viruses to cutaneous oncogenesis has steadily gained recognition. The archetype is human herpesvirus 8, which is well established as the causative agent in Kaposi sarcoma. Other viruses believed to play a role in nonmelanoma skin cancer include human papillomavirus and the recently described Merkel cell polyomavirus. We review the mechanisms by which these three viruses interact with the host cell, ultraviolet radiation and immunosuppression to result in carcinogenesis.


Subject(s)
Skin Neoplasms/virology , Tumor Virus Infections/complications , Carcinoma, Merkel Cell/virology , Carcinoma, Squamous Cell/virology , Cell Transformation, Neoplastic , Cell Transformation, Viral , Forecasting , Herpesvirus 8, Human , Humans , Immune Tolerance/physiology , Immunosuppression Therapy/adverse effects , Papillomavirus Infections/complications , Polyomavirus Infections/complications , Sarcoma, Kaposi/virology , Ultraviolet Rays/adverse effects
12.
Behav Genet ; 41(5): 700-8, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21193954

ABSTRACT

The polymorphic variation in the val158met position of the catechol-O-methyltransferase (COMT) gene is associated with differences in executive performance, processing speed, and attention. The purpose of this study is: (1) replicate previous COMT val158met findings on cognitive performance; (2) determine whether COMT val158met effects extend to a real-world task, aircraft navigation performance in a flight simulator; and (3) determine if aviation expertise moderates any effect of COMT val158met status on flight simulator performance. One hundred seventy two pilots aged 41-69 years, who varied in level of aviation training and experience, completed flight simulator, cognitive, and genetic assessments. Results indicate that although no COMT effect was found for an overall measure of flight performance, a positive effect of the met allele was detected for two aspects of cognitive ability: executive functioning and working memory performance. Pilots with the met/met genotype benefited more from increased levels of expertise than other participants on a traffic avoidance measure, which is a component of flight simulator performance. These preliminary results indicate that COMT val158met polymorphic variation can affect a real-world task.


Subject(s)
Aviation/methods , Catechol O-Methyltransferase/genetics , Cognition/physiology , Polymorphism, Genetic , Adult , Age Factors , Aged , Aircraft , Cognition Disorders/genetics , Computer Simulation , Female , Humans , Male , Methionine/genetics , Middle Aged , Neuropsychological Tests , Valine/genetics
13.
Ir J Med Sci ; 180(4): 901-3, 2011 Dec.
Article in English | MEDLINE | ID: mdl-19263184

ABSTRACT

BACKGROUND: Epidemiologic and genetic studies have suggested a bidirectional association between breast carcinoma (BC) and malignant melanoma (MM). OBSERVATION: We present a series of patients with MM and BC detected in our department within a span of 6 months, raising concerns for the high associations between the two malignancies. This led us to match the concordance of the two tumours in the National Irish Cancer Registry. CONCLUSION: The national figures provide evidence of a link between BC and MM. We recommend increased awareness among clinicians leading to more detailed surveillance of both second primary tumours. All MM patients with a family history of BC should be referred to a breast clinic. Women above the age of 40 with MM should undergo annual mammography and those less than 40 may be better evaluated with a breast MRI. All breast cancer patients should be made aware of the significance of changing moles and those with suspicious lesions referred to a dermatologist for evaluation.


Subject(s)
Breast Neoplasms/epidemiology , Melanoma/epidemiology , Neoplasms, Second Primary/epidemiology , Registries , Adult , Aged , Breast Neoplasms/diagnosis , Female , Humans , Incidence , Ireland/epidemiology , Melanoma/diagnosis
14.
Br J Dermatol ; 163(2): 345-52, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20346029

ABSTRACT

BACKGROUND: Changes in genomic DNA methylation associated with cancer include global DNA hypomethylation and gene-specific hyper- or hypomethylation. We have previously identified a genetic variant in the MTHFR gene involved in the methylation pathway which confers risk for the development of squamous cell carcinoma (SCC) in renal transplant patients. This genetic variant has also been discovered to confer SCC risk in nontransplant patients with low folate status. OBJECTIVES: To explore the methylation profile of SCC compared with adjacent non-neoplastic skin using pyrosequencing, and to elucidate whether the MTHFR polymorphism impacts upon the methylation patterns in SCC. METHODS: We used pyrosequencing to evaluate global (using long interspersed nuclear element 1) and gene-specific (p16 and MGMT) methylation status in 47 SCCs and 40 adjacent autologous non-neoplastic skin samples in those with (n = 16) and without (n = 17) the MTHFR polymorphism. RESULTS: Pyrosequencing methylation analysis revealed that SCC was hypomethylated compared with adjacent non-neoplastic skin (P < 0.04). Patients with the MTHFR polymorphism had higher levels of global methylation in tumours and non-neoplastic skin compared with those without the MTHFR polymorphism (P < 0.002). There was no association between levels of methylation in tumour and non-neoplastic skin for the genes MGMT and p16. CONCLUSIONS: Global hypomethylation appears to be a feature of SCC. Aberrant methylation of DNA appears related to polymorphisms of MTHFR. Such findings suggest that intervention in the form of demethylating agents or folate supplementation might be beneficial in the treatment or prevention of SCC.


Subject(s)
Carcinoma, Squamous Cell/genetics , DNA Methylation/genetics , Kidney Transplantation , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Neoplasm Proteins/genetics , Polymorphism, Genetic , Skin Neoplasms/genetics , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Sequence Analysis, DNA/methods
16.
Br J Dermatol ; 161 Suppl 3: 90-5, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19775363

ABSTRACT

Ultraviolet (UV) radiation is a complete carcinogen. The effects of UV radiation are mediated via direct damage to cellular DNA in the skin and suppression of image surveillance mechanisms. In the context of organ transplantation, addiction of drugs which suppress the immune system add greatly to the carcinogenicity of UV radiation. This review considers the mechanisms of such effects.


Subject(s)
Apoptosis/immunology , DNA Damage/immunology , Immunosuppression Therapy , Neoplasms, Radiation-Induced/immunology , Skin/immunology , Ultraviolet Rays/adverse effects , Animals , Apoptosis/radiation effects , DNA Damage/radiation effects , Humans , Mice , Mice, Inbred C57BL , Skin/radiation effects
17.
Br J Dermatol ; 161(3): 496-503, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19624540

ABSTRACT

Melanoma incidence continues to rise in most countries. This is of grave concern, given the mortality rate in a relatively young population. Current staging tools are limited in their ability to predict accurately those at risk of metastatic disease, relapse and treatment failure. This overview comprehensively reviews relevant literature, with the focus on the last 5 years, and discusses the current state of traditional and emerging novel methods of staging for melanoma and their effect on prognosis in this population.


Subject(s)
Melanoma/diagnosis , Neoplasm Staging/methods , Skin Neoplasms/diagnosis , Adult , Biomarkers, Tumor/analysis , Early Detection of Cancer/methods , Female , Humans , Lymphangiogenesis/physiology , Male , Melanoma/chemistry , Melanoma/classification , Middle Aged , Prognosis , Sentinel Lymph Node Biopsy , Skin Neoplasms/chemistry , Skin Neoplasms/classification , Tomography, Emission-Computed/methods , Young Adult
20.
Clin Exp Dermatol ; 34(8): e660-2, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19549230

ABSTRACT

Idiopathic solar urticaria (SU) is a rare, debilitating photodermatosis, which may be difficult to treat. First-line treatment with antihistamines is effective in mild cases, but remission after phototherapeutic induction of tolerance is often short-lived. Other treatment options include plasma exchange, photopheresis and cyclosporin. We present two cases of severe, idiopathic SU, which were resistant to conventional treatment. Both patients achieved remission after administration of intravenous immunoglobulin (IVIg) and have remained in remission at 13 months and 4 years, respectively. There are only two case reports of successful treatment of solar urticaria with IVIg. In our experience IVIg given at a total dose of 2 g/kg over several 5-day courses about a month apart is an effective treatment option for severe idiopathic SU. It is also generally safe, even if certainly subject to significant theoretical risks, such as induction of viral infection or anaphylaxis.


Subject(s)
Immunoglobulins, Intravenous/therapeutic use , Photosensitivity Disorders/drug therapy , Urticaria/drug therapy , Adult , Female , Humans , Photosensitivity Disorders/etiology , Sunlight/adverse effects , Treatment Outcome , Urticaria/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...